info@seagull-health.com
SeagullHealth
语言:
search
new
What Are the Side Effects of Trientine (Curior)?
502
Article source: Seagull Pharmacy
Sep 09, 2025

Trientine (Cuvrior) is a copper chelator primarily used for the treatment of adult patients with stable Wilson's disease who have achieved copper excretion and are tolerant to penicillamine. Its main component is trientine tetrahydrochloride, which promotes the excretion of copper ions in the body through chelation. Although its efficacy is well-established, side effects may occur during use.

What Are the Side Effects of Trientine (Curior)?

Gastrointestinal Reactions

Symptoms: Abdominal pain (19%), changes in bowel habits (15%), etc.

Relief Measures: Take the medication on an empty stomach (1 hour before a meal or 2 hours after a meal) to reduce food irritation.

Divide the daily dosage into separate administrations (twice a day, morning and evening) to avoid excessively high single doses.

Skin and Hair Abnormalities

Symptoms: Rash (12%), hair loss (8%).

Relief Measures: Mild rashes can be monitored; if they persist or worsen, discontinue the medication and consult a doctor.

Hair loss is mostly temporary, and supplementing with protein and vitamins may help improve the condition.

Mood Swings and Anemia

Symptoms: Mood swings (8%), occasional anemia (4%).

Relief Measures: Monitor mental health and seek psychological support if necessary.

Patients with anemia need to have their iron stores evaluated; if iron supplements are required, they should be taken at least 2 hours apart from trientine.

Severe Side Effects of Trientine (Curior) and Emergency Management

Neurological Deterioration

Risk: During initial treatment, neurological symptoms may worsen due to copper mobilization.

Response: Immediately adjust the dosage or discontinue the medication, and monitor serum non-ceruloplasmin copper (NCC) levels.

Copper/Iron Deficiency

Risk: Long-term medication use may lead to copper or iron deficiency, which can affect fetal development during pregnancy.

Response: Regularly monitor copper/iron levels; pregnant women must have their dosage strictly controlled.

Allergic Reactions

Symptoms: Rash, difficulty breathing, etc.

Response: Immediately discontinue the medication and seek medical attention.

Precautions for Daily Administration of Trientine (Curior)

Dosage and Administration Method

Initial Dosage: The usual dosage for adults is 750-1500 mg per day, administered orally in 2-4 divided doses.

Adjustment Principle: Adjust the dosage based on the results of NCC and 24-hour urinary copper excretion (UCE); the maximum daily dosage must not exceed 3000 mg.

Drug Interactions

Contraindicated Concurrent Use: Mineral supplements (iron, zinc, calcium, magnesium) — should be taken at an interval of 1-2 hours.

Other oral medications — should be taken at an interval of at least 1 hour.

Administration in High-Risk Populations

Pregnant Women: The risk of copper deficiency and disease control must be balanced; copper levels should be monitored throughout the pregnancy.

Elderly Patients: Start with a low dosage and pay attention to liver and kidney function.

Storage and Administration Details

Storage: Store away from light at 20-25°C; take the medication immediately after removal from storage.

Administration: Swallow the tablets whole; do not chew or dissolve them. For patients with difficulty swallowing, tablets can be split along the score line.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Indications of Trientine (Curior)
Trientine (Curior) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with stable Wilson's disease, and is particularly s...
How to Use Trientine (CUVRIOR)
Trientine (CUVRIOR) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with Wilson's disease who have achieved copper dep...
Precautions for Dacomitinib
It is of great importance for both patients and doctors to understand the precautions before using dacomitinib (Vizimpro). Dacomitinib is an oral targeted therapeutic drug, commonly used in the treatm...
Dacomitinib: Clinical Uses, Recommended Dosage, Potential Side Effects
Dacomitinib is an oral tyrosine kinase inhibitor primarily used as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR gene mutations. EGFR, ...
Indications of ExtraSuperTadarise
ExtraSuperTadarise is a combination preparation mainly used for the treatment of erectile dysfunction (ED) and premature ejaculation (PE) in men.Indications of ExtraSuperTadariseCore IndicationsErecti...
What Kind of Drug Is Dificid (Fidaxomicin)?
Dificid (fidaxomicin) is a macrolide antibacterial drug developed by Merck & Co., Inc. It was approved for marketing by the U.S. FDA in 2011. As a narrow-spectrum antibacterial agent, fidaxomicin ...
Indications of Sirolimus Albumin (Fyarro)
Sirolimus Albumin (Fyarro) is a novel antineoplastic agent specifically indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioi...
Indications of Valcyte
Valcyte (valganciclovir hydrochloride) is an antiviral prodrug, whose main component is valganciclovir hydrochloride. After oral administration, it is rapidly converted into ganciclovir in the body. A...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved